A global pharmaceutical company specialising exclusively in the research, development and marketing of medical solutions for dermatology entrusted BlueReg (BR) to validate its Publishing Software. With the objective to proceed with a major upgrade of their Publishing tool, and…
A global specialty-driven biopharmaceutical group focused on innovation and specialty care entrusted BlueReg to co-ordinate the publishing and submission of a grouped application of Type IAIN variations. This impacted several different products from the same Marketing Authorisation Holder, with different…
A global specialty-driven biopharmaceutical group focused on innovation and specialty care, entrusted to BlueReg the the preparation and coordinateion of 60 eCTD Baseline submissions for registration in Europe through the National Procedure (NP).
A global pharmaceutical company specialising exclusively in the research, development and marketing of medical solutions for dermatology recently entrusted to BlueReg the publishing of an initial Marketing Authorisation Application (MAA) dossiers for Europe, Canada & Switzerland + Responses to Questions…